For Pharma

Accelerate Cancer Stem Cell Drug Development

Our proprietary platform technology optimizes the in vitro evaluation of chemotherapy agents on cancer stem cells (CSCs) during the drug development process, allowing you to gain a better understanding of how drugs interact with CSCs before moving on to pre-clinical in vivo studies.

We provide contract services that are tailored the following:

Drug discovery targeting Cancer Stem Cells: Determining which molecules work best against which types of cancer can be challenging. Our proprietary CSC-based platform uses in vitro assays to conduct high-throughput or high-content screens to identify promising targeted agents.
Repurpose drugs and improve portfolio diversity: FDA-approved drugs can be repurposed to treat cancer by specifically targeting resistant CSCs, which will expedite and lower the cost of the approval and development process. More drugs accessible to doctors will allow for more effective first-line and recurrent cancer treatments. We can repurpose drug compounds that have been shelved or failed through new evaluation for targeting cancer stem cells using our breakthrough technology platform.

For Pharma

Accelerate Cancer Stem Cell Drug Development

We provide contract services that are tailored the following:

Registrati Ora su Hellspin Casino e Inizia a Vincere

Quick Links

Useful Links

Contact Info